Lexaria Bioscience Corp Common Stock ($0.001 par value per share) Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • August 22nd, 2024 • Lexaria Bioscience Corp. • Pharmaceutical preparations • New York
Lexaria Bioscience Corp, a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:
